- Home
- LEDS vs NXTC Comparison
LEDS vs NXTC Comparison
Compare LEDS & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- NXTC
- Stock Information
- Founded
- LEDS 2005
- NXTC 2015
- Country
- LEDS Taiwan
- NXTC United States
- Employees
- LEDS N/A
- NXTC N/A
- Industry
- LEDS Semiconductors
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- NXTC Health Care
- Exchange
- LEDS Nasdaq
- NXTC Nasdaq
- Market Cap
- LEDS 16.1M
- NXTC 13.0M
- IPO Year
- LEDS 2010
- NXTC 2019
- Fundamental
- Price
- LEDS $1.93
- NXTC $5.40
- Analyst Decision
- LEDS
- NXTC Strong Buy
- Analyst Count
- LEDS 0
- NXTC 2
- Target Price
- LEDS N/A
- NXTC $25.50
- AVG Volume (30 Days)
- LEDS 67.5K
- NXTC 16.7K
- Earning Date
- LEDS 07-11-2025
- NXTC 11-06-2025
- Dividend Yield
- LEDS N/A
- NXTC N/A
- EPS Growth
- LEDS N/A
- NXTC N/A
- EPS
- LEDS N/A
- NXTC N/A
- Revenue
- LEDS $31,108,000.00
- NXTC N/A
- Revenue This Year
- LEDS N/A
- NXTC N/A
- Revenue Next Year
- LEDS N/A
- NXTC N/A
- P/E Ratio
- LEDS N/A
- NXTC N/A
- Revenue Growth
- LEDS 485.62
- NXTC N/A
- 52 Week Low
- LEDS $0.92
- NXTC $2.69
- 52 Week High
- LEDS $3.16
- NXTC $19.20
- Technical
- Relative Strength Index (RSI)
- LEDS 53.82
- NXTC 57.83
- Support Level
- LEDS $1.61
- NXTC $4.77
- Resistance Level
- LEDS $1.91
- NXTC $5.15
- Average True Range (ATR)
- LEDS 0.17
- NXTC 0.22
- MACD
- LEDS 0.03
- NXTC 0.05
- Stochastic Oscillator
- LEDS 28.32
- NXTC 86.90
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.